Commentary

Podcast

Updates to Acute Coronary Syndrome Guidelines

Author(s):

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP ,Aislinn Antrim, Managing Editor

Host Craig Beavers speaks with Steven Dunn about the latest ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes.

This week, expert Steven Dunn, PharmD, FAHA, FCCP, BCCP, discusses the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Read the guidelines here.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Image credit: Jack Fotografo | stock.adobe.com
Related Content
Heart-healthy foods -- Image credit: marilyn barbone | stock.adobe.com
June 11th 2025

The Role of Pharmacists in Cardiovascular Health: A Collaborative Approach to Treatment, Counseling, and Nutrition

Megan Smith, PharmD
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction
June 2nd 2025

NLA 2025: Bempedoic Acid Supports ASCVD Prevention and LDL-C Reduction

Steven E. Nissen, MD, MACC Alana Hippensteele, Lead Editor
New Programs Aim to Improve Implementation of Cardiovascular Interventions
June 3rd 2025

New Programs Aim to Improve Implementation of Cardiovascular Interventions

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
FDA approval of treprostinil (Yutrepia) -- Image credit: Pakin | stock.adobe.com
May 27th 2025

FDA Approves Treprostinil Inhalation Powder for PAH and PH-ILD

Gillian McGovern, Associate Editor
AI-generated depiction of a heart -- Image credit: Vasili | stock.adobe.com
May 26th 2025

GADD45A May Prevent Inflammation, Fibrosis, and Preserve Cardiac Function

Gillian McGovern, Associate Editor